Outcome prognostic factors in inoperable malignant bowel obstruction

被引:9
|
作者
Romeo, Margarita [1 ,2 ]
de los LLanos Gil, Maria [1 ]
Cuadra Urteaga, Jose Luis [1 ]
Vila, Laia [1 ]
Ahlal, Sara [1 ]
Indacochea, Alberto [1 ,3 ]
Pardo, Nuria [1 ,4 ]
Radua, Joaquim [5 ,6 ]
Font, Albert [1 ]
Tuca, Albert [7 ]
机构
[1] Inst Catala Oncol, Dept Med Oncol, Carretera Canyet S-N, Badalona 08916, Spain
[2] Univ Autonoma Barcelona, Barcelona, Spain
[3] Vall dHebron Inst Recerca, CRG, Barcelona, Spain
[4] Hosp Valle De Hebron, Vall dHebron Inst Oncol, Dept Med Oncol, Barcelona, Spain
[5] FIDMAG Germanes Hosp CIBERSAM, St Boi De Llobregat, Spain
[6] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Solna, Sweden
[7] Hosp Clin Barcelona, Dept Med Oncol, Support Care Canc Unit, Barcelona, Spain
关键词
Malignant bowel obstruction; Octreotide; Hyoscine butylbromide; Prognostic factors; SCOPOLAMINE BUTYLBROMIDE; DOUBLE-BLIND; PHARMACOLOGICAL-TREATMENT; HYOSCINE BUTYLBROMIDE; RANDOMIZED-TRIAL; SYMPTOM CONTROL; CLINICAL-TRIAL; OCTREOTIDE; CANCER; MANAGEMENT;
D O I
10.1007/s00520-016-3299-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inoperable malignant bowel obstruction (MBO), a severe complication of peritoneal carcinomatosis, has a low desobstruction rate (30-40 %) and end-of-life decision-making is hampered by the lack of known prognostic factors. This study aimed to explore prognostic factors for desobstruction in MBO. All patients with inoperable MBO admitted in our large oncology hospital between 2010 and 2013 were treated following a clinical protocol based on antiemetics, steroids and two antisecretories, octreotide, and hyoscine butylbromide. Two prognostic factor analyses using logistic regressions were performed, one based on data from day 1 of admission and the other on data from day 8. Forty-five patients were included. Frequency of desobstruction was 48.9 %. In the analysis of prognostic factors on day 1, MBO episodes derived from functional physiopathologic mechanisms (vs. mechanic or mixed) were more prone to resolve (p < 0.001 corrected for multiple comparisons). Considering patients alive with persistent obstruction on day 8, a better clinical condition was the variable more associated with desobstruction, but without statistical significance after correction for multiple comparisons. A functional physiopathologic mechanism of MBO development may be an early prognostic factor for desobstruction. A high proportion of desobstruction was observed, suggesting that the combination of antisecretories with different mechanism of action warrants further investigation.
引用
收藏
页码:4577 / 4586
页数:10
相关论文
共 50 条
  • [21] PROGNOSTIC FACTORS FOR OVERALL SURVIVAL IN MALIGNANT URETERAL OBSTRUCTION
    Creswell, Michael
    Egan, Jillian
    Mason, J. Bradley
    Dall, Christopher
    Sholklapper, Tamir
    Galloway, Lan Anh
    Orzel, Joanna
    Lee, Harry
    Desale, Sameer
    Stamatakis, Lambros
    JOURNAL OF UROLOGY, 2021, 206 : E943 - E944
  • [22] Malignant bowel obstruction
    Krouse, Robert S.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (01) : 74 - 77
  • [23] Malignant Bowel Obstruction
    Zorn, M.
    Domagk, D.
    Auerbauch, T.
    Mais, J.
    Brauckhoff, T.
    Holtmann, M. H.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2010, 48 (02): : 264 - 273
  • [24] MALIGNANT BOWEL OBSTRUCTION
    Ferretti, Deborah
    JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING, 2010, 37 (03) : S16 - S17
  • [25] Malignant bowel obstruction
    Tuca, Albert
    Martinez, Emilio
    Gueell, Ernest
    Gomez Batiste, Xavier
    MEDICINA CLINICA, 2010, 135 (08): : 375 - 381
  • [26] Management of symptoms due to inoperable bowel obstruction
    Ripamonti, C
    Fagnoni, E
    Magni, A
    TUMORI JOURNAL, 2005, 91 (03): : 233 - 236
  • [27] Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction
    S. Mercadante
    C. Ripamonti
    A. Casuccio
    E. Zecca
    L. Groff
    Supportive Care in Cancer, 2000, 8 : 188 - 191
  • [28] Inoperable malignant bowel obstruction: palliative interventions outcomes - mixed-methods systematic review
    Patterson, Michael
    Greenley, Sarah
    Ma, Yangmyung
    Bullock, Alex
    Curry, Jordan
    Smithson, Jacquelyn
    Lind, Michael
    Johnson, Miriam J.
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2023, 13 (E3) : e515 - e527
  • [29] Palliative Medical Management of Inoperable Malignant Bowel Obstruction With "Triple Therapy": Dexamethasone, Octreotide, and Metoclopramide
    Wey, Winston
    Mian, Moeena
    Calabrese, Rebecca
    Hansen, Eric
    Walter, Michelle
    Wang, Chong
    Miller, Austin
    Case, Amy A.
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2021, 38 (04): : 340 - 345
  • [30] Triple or Drug Combination for the Medical Management of Inoperable Malignant Bowel Obstruction: Does It Make a Difference?
    Mercadante, Sebastiano
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2024, 67 (06) : e917 - e918